Evidence map›Paper›PMID 40920212›Full record

ReviewAdvances in biochemical engineering/biotechnology2025

Exploitation of Biodiversity in Bioeconomy: Examples, Opportunities, and Challenges.

Alexander Grünberger, Emily Schepp, Selina Lang, Kevin Edward Schulz, Daniel Baron Diaz, Arabi Sivanesapillai, Andreas Diepold, Camilla Stolle, Kersten Rabe, Roland Ulber and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in biochemical engineering/biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexander GrünbergerInstitute of Process Engineering in Life Sciences, Microsystems in Bioprocess Engineering, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Emily ScheppInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Selina LangInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Kevin Edward SchulzInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Daniel Baron DiazInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Arabi SivanesapillaiInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Andreas DiepoldInstitute of Applied Biosciences, Applied Biology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Camilla StolleInstitute for Biological Interfaces 1, Biomolecular Micro- and Nanostructures, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Kersten RabeInstitute for Biological Interfaces 1, Biomolecular Micro- and Nanostructures, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Roland UlberInstitute of Bioprocess Engineering, University of Kaiserslautern-Landau, Kaiserslautern, Germany.
Dirk HoltmannInstitute of Process Engineering in Life Sciences, Electrobiotechnology, Karlsruhe Institute of Technology, Karlsruhe, Germany. dirk.holtmann@kit.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While bioprocesses using Escherichia coli, Corynebacterium glutamicum, various species of Bacillus, lactic acid bacteria, Clostridia, the yeasts Saccharomyces cerevisiae and Pichia pastoris, fungi such as Aspergillus niger, and Chinese hamster ovary cells are well established, the high level of microbial diversity has not yet been exploited industrially. However, the use of alternative organisms has the potential to significantly expand the process window of bioprocesses. These extensions include the use of alternative substrates (e.g., CO

Indexed as

BiodiversityIndustrial MicrobiologyAnimalsAlternative organismsAlternative substratesBiofilmsC1-substratesElectro-biotechnologyProcess windowsUnusual process conditions

Identifiers

PMID40920212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.